The briefing
Researchers report a nanoparticle-based combination approach that reduced treatment-resistant oral squamous cell carcinoma in preclinical models. The work targets a cancer with roughly 50% five-year survival, though findings remain early-stage.
Original headline
Lipid nanoparticles deliver one-two punch to shrink resistant oral tumors in preclinical models